Surgical experience with hepatic colorectal metastasis.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 10366210)

Published in Am Surg on June 01, 1999

Authors

A L Bradley1, W C Chapman, J K Wright, J W Marsh, S Geevarghese, K T Blair, C W Pinson

Author Affiliations

1: Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, Tennessee 37232-4753, USA.

Articles citing this

Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer (2006) 3.26

Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol (2012) 1.69

Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs. World J Surg (2013) 0.88

Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases. World J Surg (2001) 0.85

Surveillance of patients following surgery with curative intent for colorectal cancer. World J Gastroenterol (2007) 0.85

Long-term outcome after sequential resections of liver and lung metastases from colorectal carcinoma. HPB (Oxford) (2009) 0.83

Surgical treatment of liver metastases from colorectal cancer in elderly patients. Int J Colorectal Dis (2006) 0.81

Surgical outcomes after resection of both hepatic and pulmonary metastases from colorectal cancer. World J Surg (2012) 0.80

Hepatocellular carcinoma: preclinical data on a dual-lumen catheter kit for fibrin sealant infusion following loco-regional treatments. Infect Agent Cancer (2014) 0.78

Predictors of early recurrence after resection of colorectal liver metastases. World J Surg Oncol (2015) 0.75

Comparison of Hepatic Resection and Radiofrequency Ablation for the Treatment of Colorectal Liver Metastasis. Indian J Surg (2015) 0.75

Minimally invasive surgery using the open magnetic resonance imaging system combined with video-assisted thoracoscopic surgery for synchronous hepatic and pulmonary metastases from colorectal cancer: report of four cases. Surg Today (2014) 0.75

Articles by these authors

Lactose carrier protein of Escherichia coli. Structure and expression of plasmids carrying the Y gene of the lac operon. Eur J Biochem (1980) 3.24

Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science (2001) 3.02

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87

A meta-analysis of selective versus routine nasogastric decompression after elective laparotomy. Ann Surg (1995) 2.58

Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest (1994) 2.33

The mannose-sensitive hemagglutinin of Vibrio cholerae promotes adherence to zooplankton. Appl Environ Microbiol (2001) 2.23

Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22

In vitro and in vivo products of E. coli lactose permease gene are identical. Nature (1980) 2.18

Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J Virol (1994) 2.17

Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg (1998) 1.99

HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc Natl Acad Sci U S A (1999) 1.92

Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc (1987) 1.90

Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant (2012) 1.88

Improving the outcome in gallstone ileus. Am J Surg (1986) 1.87

The structure of the lactose permease derived from Raman spectroscopy and prediction methods. EMBO J (1985) 1.79

The mechanism of inducer exclusion. Direct interaction between purified III of the phosphoenolpyruvate:sugar phosphotransferase system and the lactose carrier of Escherichia coli. EMBO J (1983) 1.78

Hepatic artery in liver transplantation. Transplant Proc (1987) 1.73

Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J Virol (1996) 1.69

Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Cancer (1996) 1.69

Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology (1994) 1.64

Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg (1998) 1.63

Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant (2009) 1.59

Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology (1992) 1.58

The requirements for viral entry differ from those for virally induced syncytium formation in NIH 3T3/DTras cells exposed to Moloney murine leukemia virus. J Virol (1992) 1.58

Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. Am J Transplant (2013) 1.54

Should hepatomas be treated with hepatic resection or transplantation? Cancer (1999) 1.54

Anti-peptide antibodies and proteases as structural probes for the lactose/H+ transporter of Escherichia coli: a loop around amino acid residue 130 faces the cytoplasmic side of the membrane. Biochemistry (1986) 1.53

Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol (2008) 1.53

Peptide-specific antibody locates the COOH terminus of the lactose carrier of Escherichia coli on the cytoplasmic side of the plasma membrane. J Biol Chem (1983) 1.51

Acute lung injury after hepatic cryoablation: correlation with NF-kappa B activation and cytokine production. Surgery (1999) 1.50

Comparison of laparoscopic cholecystectomy with open cholecystectomy in a single center. Am J Surg (1993) 1.49

Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med (1997) 1.47

Orthotopic liver transplantation for alcoholic cirrhosis. JAMA (1988) 1.45

Hepatic venous outflow obstruction in pediatric liver transplantation: technical considerations in prevention, diagnosis, and management. Pediatr Transplant (2014) 1.40

Nashville experience with liver transplantation in Veterans Administration patients. J Surg Res (1997) 1.39

A comparison of single photon and dual X-ray absorptiometry of the forearm in children and adults. Bone (1994) 1.38

Sidedness of native membrane vesicles of Escherichia coli and orientation of the reconstituted lactose: H+ carrier. Eur J Biochem (1984) 1.37

Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology (1997) 1.36

OKT3 in the reversal of acute hepatic allograft rejection. Transplant Proc (1987) 1.35

Purification of the lactose:H+ carrier of Escherichia coli and characterization of galactoside binding and transport. Eur J Biochem (1984) 1.34

Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (2000) 1.33

18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg (1999) 1.32

Molecular aspects of sugar:ion cotransport. Annu Rev Biochem (1986) 1.29

Lactose carrier protein of Escherichia coli: interaction with galactosides and protons. Biochemistry (1981) 1.28

Analysis of surgical complications after 397 hepatic transplantations. Surg Gynecol Obstet (1990) 1.25

Surgical management of leiomyosarcoma of the inferior vena cava. J Gastrointest Surg (2008) 1.24

Variation in management based on type of choledochal cyst. Am J Surg (1991) 1.24

Experience with primary liver transplantation across ABO blood groups. Transplant Proc (1987) 1.23

ICRP Publication 115. Lung cancer risk from radon and progeny and statement on radon. Ann ICRP (2010) 1.21

Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med (1999) 1.19

Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg (1996) 1.19

Image-guided surgery: preliminary feasibility studies of frameless stereotactic liver surgery. Arch Surg (1999) 1.19

General surgical complications after cardiopulmonary bypass surgery. Am J Surg (1983) 1.16

Adult to adult living-related liver transplant: report on an initial experience in Italy. Dig Liver Dis (2007) 1.16

Extended right hepatic lobectomy, left hepatic lobectomy, and skeletonization resection for proximal bile duct cancer. World J Surg (1988) 1.14

A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation (1999) 1.14

A comparison of 399 open and 568 laparoscopic gastric bypasses performed during a 4-year period. Surg Endosc (2007) 1.13

Transplantation for primary biliary cirrhosis. Gastroenterology (1988) 1.12

Distinct functions of monoclonal IgG antibody depend on antigen-site specificities. J Exp Med (1979) 1.12

Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery (1990) 1.11

Liver transplantation in the treatment of bleeding esophageal varices. Surgery (1988) 1.11

Bile duct injury following laparoscopic cholecystectomy: a cause for continued concern. Am Surg (2001) 1.08

Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg (1999) 1.08

Surface registration for use in interactive, image-guided liver surgery. Comput Aided Surg (2000) 1.08

Isolation of the globular region of the subcomponent q of the C1 component of complement. Hoppe Seylers Z Physiol Chem (1979) 1.08

The size of the lactose permease derived from rotational diffusion measurements. EMBO J (1985) 1.08

Management of biliary complications after liver transplantation. Am J Surg (1992) 1.08

Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenase. Matrix (1992) 1.07

Does the lactose carrier of Escherichia coli function as a monomer? FEBS Lett (1983) 1.07

Management of bronchobiliary fistula as a late complication of hepatic resection. Am Surg (1998) 1.05

Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology (1990) 1.05

FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation (1995) 1.05

Dysphagia lusoria: aberrant right subclavian artery with a Kommerell's diverticulum. Am Surg (1993) 1.04

Repeat hepatic surgery for colorectal cancer metastasis to the liver. Ann Surg (1996) 1.04

The Vibrio cholerae mannose-sensitive hemagglutinin is the receptor for a filamentous bacteriophage from V. cholerae O139. Infect Immun (1998) 1.02

Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix complement. Biochem J (1980) 1.02

Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology (2000) 1.01

Ischemic colitis. An ever-changing spectrum? Am Surg (1991) 1.01

HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells. J Biol Chem (1994) 1.01